Ballentine Partners LLC boosted its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 40.7% in the fourth quarter, ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

GSK's Jemperli wins EU approval for broader use in advanced endometrial cancer, showing improved survival and significant ...

PharmaCord Founder and CEO Nitin Sahney will continue to serve on the Board of Directors and remains a significant investor in the Company. Since founding PharmaCord in 2017, Sahney has led the ...

“We are pleased to welcome Reena to Applied and are confident that her wealth of experience as a leader across quality functions will support our mission of meeting the unmet needs of patients with ...

GSK (NYSE:GSK – Get Free Report) was downgraded by investment analysts at StockNews.com from a “strong-buy” rating to a “buy” ...

Over the weekend, Chiefs Wire’s Ed Easton Jr. spoke to accomplished actress Gina Torres at a remarkable and informative women ...

The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...

After what some real estate experts are calling a capital crisis, momentum in Saskatchewan and Canada’s commercial real estate investment market is finally bouncing back. “Interest rates have ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

"Combining our experience to date with GSK’s expertise in GI cancers, global clinical development capability, and strong commercial presence in oncology will help to accelerate the development ...